Argent Biopharma Limited has released a press release.
Priority Offer Timetable - Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Supplementary Prospectus
- European Commission Approves MGC Derma Cosmetics Products
- ASX Approval of Panax Transaction and Capital Raising Update
- MXC to Raise $5.0m - Capital Raising Oversubscribed
- MXC to Acquire Licensed European Medical Cannabis Company
Later from Argent Biopharma
- Prospectus - Priority Offer
- Shareholder Priority Offer Closed Early - Oversubscribed
- FDA Approval Granted and First US Distribution Deal Signed
- Health Canada Approves MGC Derma CBD Cosmetics
- MXCs First Crops Planted at European CBD Production Farm
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma